Cargando…
Optimal management of familial hypercholesterolemia: treatment and management strategies
Familial hypercholesterolemia is an autosomally dominant disorder caused by various mutations in low-density lipoprotein receptor genes. This will lead to elevated levels of total and low-density lipoprotein cholesterol, which may in turn lead to premature coronary atherosclerosis and cardiac-relate...
Autores principales: | Nemati, Mohammad Hassan, Astaneh, Behrooz |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004511/ https://www.ncbi.nlm.nih.gov/pubmed/21191428 http://dx.doi.org/10.2147/VHRM.S8283 |
Ejemplares similares
-
The Effect of Mipomersen in the Management of Patients with Familial Hypercholesterolemia: A Systematic Review and Meta-Analysis of Clinical Trials
por: Astaneh, Behrooz, et al.
Publicado: (2021) -
Amiodarone Versus Propafenone to Treat Atrial Fibrillation after Coronary Artery Bypass Grafting: A Randomized Double Blind Controlled Trial
por: Nemati, Mohammad Hassan, et al.
Publicado: (2016) -
Outcome and Graft Patency in Coronary Artery Bypass Grafting with Coronary Endarterectomy
por: Nemati, Mohammad Hassan, et al.
Publicado: (2015) -
Familial Hypercholesterolemia: A Narrative Review on Diagnosis and Management Strategies for Children and Adolescents
por: Tada, Hayato, et al.
Publicado: (2021) -
Management of Familial Hypercholesterolemia with Special Emphasis on Evinacumab
por: Krzemińska, Julia, et al.
Publicado: (2022)